|Mr. Marc Edwards||Pres, CEO & Director||279.45k||N/A||N/A|
|Mr. Ray Dupuis||Chief Financial Officer||187.37k||N/A||N/A|
|Dr. Gordon Guay||Chief Scientific Officer & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Lorne Gorber||Investor Relations||N/A||N/A||N/A|
|Ms. Lori Christofalos||Director of Quality & Compliance||N/A||N/A||N/A|
|Ms. Wendy Nachtigall||Director of Marketing||N/A||N/A||N/A|
|Mr. Kevin Cole||Pres & CEO of STEM Animal Health Inc||N/A||N/A||N/A|
|Mr. Mark Ahrens-Townsend||Advisor||N/A||N/A||N/A|
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; medical device coatings under the Aledex name; and shampoos for dogs, cats, and horses under the Alosera name. It also offers anti-itch shampoo under the silkstem name; scalp detoxifiers, shampoos, and shampoo bars under the DermaKB Biofilm brand name; and wound care products under the Coactiv+ name. The company was incorporated in 2001 and is based in Winnipeg, Canada.
Kane Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.